Kirby McInerney LLP | Financial Litigation Law Firm | <h3 >Natera, Inc. Investigation</h3 >
This links to the home page
Cases
PRACTICE AREAS

Natera, Inc. Investigation


The law firm of Kirby McInerney LLP is investigating potential claims against Natera, Inc. (“Natera” or the “Company”) (NASDAQ: NTRA). The investigation concerns whether Natera has violated the federal securities laws and/or engaged in other unlawful business practices.
 
Natera is a diagnostics company that develops and commercializes molecular testing services worldwide.
 
On January 1, 2022, an article from the New York Times called into question the accuracy of certain prenatal tests, alleging that positive results on tests are incorrect about 85 percent of the time, and that patients who receive a positive result are supposed to pursue follow-up testing, which “can cost thousands of dollars, come with a small risk of miscarriage and can’t be performed until later in pregnancy.” On this news, Natera’s stock price declined by $2.06 per share, or approximately 2.21%, from $93.39 per share to close at $91.33 per share on January 3, 2022.
 

Natera, Inc. Investor Contact Form